The Maryland Sickle Cell Disease Ssociation Incorporated
Maryland Sickle Cell Disease Association experiences significant revenue growth but a deficit in 2023.
EIN: 205906340 · Columbia, MD · NTEE: G80 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $482K |
| Total Expenses | $356K |
| Program Spending | 70% |
| Net Assets | $169K |
| Transparency Score | 65/100 |
Is The Maryland Sickle Cell Disease Ssociation Incorporated Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
The Maryland Sickle Cell Disease Ssociation Incorporated directs 70% of its spending to programs. This meets the industry benchmark of 65% for efficient nonprofits.
About The Maryland Sickle Cell Disease Ssociation Incorporated
The Maryland Sickle Cell Disease Ssociation Incorporated (EIN: 205906340) is a nonprofit organization based in Columbia, MD, classified under NTEE code G80. The organization reported total revenue of $482K and total assets of $117K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of The Maryland Sickle Cell Disease Ssociation Incorporated's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
The Maryland Sickle Cell Disease Ssociation Incorporated is a small nonprofit that has been operating for 18 years, with 3 years of IRS 990 filings on record (2021–2023). Revenue has grown at a compound annual rate of 106.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $338K |
| Total Expenses | $356K |
| Surplus / Deficit | $-18,579 |
| Total Assets | $169K |
| Net Assets | $169K |
| Operating Margin | -5.5% |
| Months of Reserves | 5.7 months |
Financial Health Grade: B
In 2023, The Maryland Sickle Cell Disease Ssociation Incorporated reported a deficit of $19K with expenses exceeding revenue, holds 5.7 months of operating reserves (adequate).
Financial Trends
Over 3 years of filings (2021–2023), The Maryland Sickle Cell Disease Ssociation Incorporated's revenue has grown at a compound annual growth rate (CAGR) of 106.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +79.5% | +337.5% | -10.4% |
| 2022 | +137.1% | +202.6% | +130.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2008 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates The Maryland Sickle Cell Disease Ssociation Incorporated with a Mission Score of 65 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 20%
- programs: 70%
- fundraising: 10%
According to IRS 990 filings, The Maryland Sickle Cell Disease Ssociation Incorporated allocates its expenses as follows: admin: 20%, programs: 70%, fundraising: 10%. Approximately 70% goes to programs, indicating moderate mission focus.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $19K, with expenses exceeding revenue.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available periods, indicating that officers are not receiving salaries, which is a strong positive for donor confidence and suggests a volunteer-driven leadership model.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of The Maryland Sickle Cell Disease Ssociation Incorporated's IRS 990 filings:
- Expenses ($356,089) exceeded revenue ($337,510) in 2023, leading to a deficit.
- Significant increase in expenses in 2023 without a clear functional breakdown.
- Decline in assets from $188,701 in 2022 to $169,121 in 2023.
Strengths
The following positive indicators were identified for The Maryland Sickle Cell Disease Ssociation Incorporated:
- Strong revenue growth from $79,329 in 2021 to $337,510 in 2023.
- Consistent 0% officer compensation, indicating volunteer leadership.
- No reported liabilities across all filing periods, suggesting good debt management.
- Consistent filing of IRS Form 990s, demonstrating regulatory compliance.
Frequently Asked Questions about The Maryland Sickle Cell Disease Ssociation Incorporated
Is The Maryland Sickle Cell Disease Ssociation Incorporated a legitimate charity?
The Maryland Sickle Cell Disease Ssociation Incorporated (EIN: 205906340) is a registered tax-exempt nonprofit based in Maryland. Our AI analysis gives it a Mission Score of 65/100. It has 3 years of IRS 990 filings on record. Total revenue: $482K. 3 red flags identified. 4 strengths noted. Financial health grade: B.
How does The Maryland Sickle Cell Disease Ssociation Incorporated spend its money?
The Maryland Sickle Cell Disease Ssociation Incorporated directs 70% of its spending to programs and services. Fundraising costs 10%. This meets the 65% industry benchmark.
Are donations to The Maryland Sickle Cell Disease Ssociation Incorporated tax-deductible?
The Maryland Sickle Cell Disease Ssociation Incorporated is registered as a tax-exempt nonprofit (EIN: 205906340). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of The Maryland Sickle Cell Disease Ssociation Incorporated's spending goes to programs?
The Maryland Sickle Cell Disease Ssociation Incorporated directs 70% to programs, 10% to fundraising. This meets the 65% industry benchmark for efficient nonprofits.
How does The Maryland Sickle Cell Disease Ssociation Incorporated compare to similar nonprofits?
With a transparency score of 65/100 (Good), The Maryland Sickle Cell Disease Ssociation Incorporated is above average for NTEE category G80 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is The Maryland Sickle Cell Disease Ssociation Incorporated located?
The Maryland Sickle Cell Disease Ssociation Incorporated is headquartered in Columbia, Maryland and files with the IRS under EIN 205906340. It is classified under NTEE code G80.
How many years of IRS 990 filings does The Maryland Sickle Cell Disease Ssociation Incorporated have?
The Maryland Sickle Cell Disease Ssociation Incorporated has 3 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data. The most recent filing shows $482K in total revenue.
Is The Maryland Sickle Cell Disease Association Incorporated financially sustainable given the 2023 deficit?
The organization reported expenses of $356,089 against revenues of $337,510 in 2023, resulting in a deficit. While assets are still positive at $169,121, sustained deficits could impact long-term sustainability.
How does the organization allocate its expenses, particularly the significant increase in 2023?
The provided data does not offer a detailed functional expense breakdown (programs, admin, fundraising). The substantial jump in expenses from $81,388 in 2022 to $356,089 in 2023 warrants further investigation into its allocation.
What caused the decline in assets from $188,701 in 2022 to $169,121 in 2023?
The asset decline of approximately $19,580 coincides with the $18,579 deficit in 2023, suggesting that the organization used its reserves to cover the shortfall in expenses over revenue.
Filing History
IRS 990 filing history for The Maryland Sickle Cell Disease Ssociation Incorporated showing financial trends over 3 years of public records:
Over 3 years of IRS 990 filings (2021–2023), The Maryland Sickle Cell Disease Ssociation Incorporated's revenue has grown by 325.5%, moving from $79K to $338K. Total assets increased by 106.2% over the same period, from $82K to $169K. Total functional expenses rose by 1224.1%, from $27K to $356K. In its most recent filing year (2023), The Maryland Sickle Cell Disease Ssociation Incorporated reported a deficit of $19K, with expenses exceeding revenue.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $338K | $356K | $169K | $0 | — | — |
| 2022 | $188K | $81K | $189K | $0 | — | View 990 |
| 2021 | $79K | $27K | $82K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $338K, expenses of $356K, and assets of $169K (revenue +79.5% year-over-year).
- 2022: Revenue of $188K, expenses of $81K, and assets of $189K (revenue +137.1% year-over-year).
- 2021: Revenue of $79K, expenses of $27K, and assets of $82K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for The Maryland Sickle Cell Disease Ssociation Incorporated:
Data Sources and Methodology
This transparency report for The Maryland Sickle Cell Disease Ssociation Incorporated is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.